Can Older Breast Cancer Patients Tolerate Immunotherapy Plus Chemotherapy? - Takeaways - MDSpire
Advertisement
Can Older Breast Cancer Patients Tolerate Immunotherapy Plus Chemotherapy?
Using a newer combination of immunotherapy and lower doses of chemotherapy, USC Norris Comprehensive Cancer Center experts treated a 79-year-old woman with triple-negative breast cancer.
USC Norris Comprehensive Cancer Center treated a 79-year-old woman with triple-negative breast cancer using immunotherapy and lower chemotherapy doses.
2
Triple-negative breast cancer is aggressive and has a high recurrence rate, requiring careful treatment consideration in older patients.
3
The patient achieved a complete pathologic response after treatment, indicating no remaining cancer cells and a better overall survival rate.
4
Chemotherapy doses were lowered and administered weekly to monitor the patient's response and manage potential side effects closely.
5
Circulating tumor cell tests are more effective than older methods for detecting breast cancer recurrence, showing up to 95%-97% accuracy.
